|
Volumn 27, Issue 11, 2009, Pages 971-972
|
Steve Reed
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT;
INFLUENZA VACCINE;
TOLL LIKE RECEPTOR 4;
IMMUNOLOGICAL ADJUVANT;
VACCINE;
BIOTECHNOLOGY;
DEVELOPING COUNTRY;
DIARRHEA;
FOOD AND DRUG ADMINISTRATION;
FUNDING;
HEALTH CARE ORGANIZATION;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A H1N1;
MEDICAL RESEARCH;
NOTE;
PANDEMIC;
PRIORITY JOURNAL;
ARTICLE;
ECONOMICS;
IMMUNOLOGY;
INTERVIEW;
RARE DISEASE;
VIROLOGY;
ADJUVANTS, IMMUNOLOGIC;
BIOTECHNOLOGY;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
RARE DISEASES;
VACCINES;
|
EID: 70449371403
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1109-971 Document Type: Note |
Times cited : (1)
|
References (0)
|